HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

9-cis-retinoic acid analogues with bulky hydrophobic rings: new RXR-selective agonists.

Abstract
Stille cross-coupling of aryltriflates 10 and dienylstannane 11, oxidation and Horner-Wadsworth-Emmons reaction afforded stereoselectively retinoates 15. Saponification provided the carboxylic acids 8a and 8b, retinoids that incorporate a bulky hydrophobic ring while preserving the 9-cis-geometry of the parent system. In contrast to the pan-RAR/RXR agonistic profile of the lower homologue of 8a, compound 7 (LG100567), retinoids 8 showed selective binding and transactivation of RXR, devoid of significant RAR activation. In PLB985 leukemia cells that require RXR agonists for differentiation compounds 8 induced maturation in the presence of the RAR-selective pan-agonist TTNPB; this effect was blocked by an RXR-selective antagonist.
AuthorsRosana Alvarez, M Jesús Vega, Sabrina Kammerer, Aurélie Rossin, Pierre Germain, Hinrich Gronemeyer, Angel R de Lera
JournalBioorganic & medicinal chemistry letters (Bioorg Med Chem Lett) Vol. 14 Issue 24 Pg. 6117-22 (Dec 20 2004) ISSN: 0960-894X [Print] England
PMID15546741 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Ligands
  • Nicotinic Acids
  • Receptors, Retinoic Acid
  • Retinoid X Receptors
  • Alitretinoin
  • Tretinoin
Topics
  • Alitretinoin
  • Hydrophobic and Hydrophilic Interactions
  • Ligands
  • Models, Molecular
  • Molecular Structure
  • Nicotinic Acids (chemical synthesis, chemistry, pharmacology)
  • Receptors, Retinoic Acid (agonists)
  • Retinoid X Receptors (agonists)
  • Structure-Activity Relationship
  • Tretinoin (chemical synthesis, chemistry, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: